Healthcare - Biotechnology - NASDAQ - US
$ 5.29
-5.54 %
$ 307 M
Market Cap
-3.98
P/E
CASH FLOW STATEMENT
-57.4 M
OPERATING CASH FLOW
48.7 M
INVESTING CASH FLOW
63 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Rezolute, Inc.
| Net Income | -68.5 M |
| Depreciation & Amortization | 36 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 7.36 M |
| Change in Working Capital | 3.1 M |
| Others | 2.61 M |
| Free Cash Flow | -57.4 M |
Cash Flow
Millions
| Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 | Jun-2020 | Jun-2019 | Jun-2018 | Jun-2017 | Jun-2016 | Jun-2015 | Jun-2014 | Jun-2013 | Jun-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (68.5) | (51.8) | (41.1) | (20.9) | (20.3) | (30.4) | (29.9) | (20.3) | (14.9) | (11.4) | (9.7) | (6.7) | 49.3 K |
| Depreciation & Amortization | 36 K | 30 K | 13 K | 13 K | 18 K | 49 K | 1.1 | 1.1 | 0.8 | 0.1 | 11.3 K | 295 | 221 |
| Deferred Income Tax | 0 | (1.4) | 0 | (1.8) | 0.1 | 17 K | 2.9 | 0 | 0 | 0.8 | 4.6 | 0 | 0 |
| Stock Based Compensation | 7.4 | 7.3 | 3.7 | 4.0 | 3.3 | 2.6 | 5.1 | 6.0 | 3.8 | 2.8 | 1.1 | 3.7 | 0 |
| Other Operating Activities | 0.6 | 0.4 | (1.6) | 0.4 | 0.2 | 4.1 | 5.6 | 1.2 K | 53.2 K | 0.2 | 0.4 | 0.5 | 9.78 K |
| Change in Working Capital | 3.1 | 1.0 | (0.6) | (2.1) | (7.5) | 8.4 | 1.0 | (0.2) | (0.1) | 0.4 | 0.5 | 1.0 | 1.11 K |
| Cash From Operations | (57.4) | (44.5) | (39.6) | (20.4) | (24.2) | (15.3) | (14.1) | (13.3) | (10.5) | (7.1) | (3.2) | (1.6) | 40.4 K |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | 0 | (0.2) | 0 | 0 | 0 | 47 K | 5.82 K | (0.4) | (2.1) | (3.2) | 70 K | 11.7 K | 2 K |
| Other Items | 48.7 | (101.3) | 0 | 0 | 0 | 0.3 | 1.7 | 0.2 | 0.6 | (0.5) | (0.8) | 0.2 | 0 |
| Cash From Investing Activities | 48.7 | (101.5) | 0 | 0 | 0 | 0.2 | 1.7 | (0.2) | (1.5) | (3.6) | (0.8) | 0.2 | 2 K |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | (16.0) | 15.0 | 0 | 0 | 5.3 | 23.1 K | 93.9 K | 67.9 K | 2.6 | 1.6 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 14.0 | (0.8) | 42.2 | (4.5) | (1.5) | 25.0 | (0.3) | (0.7) | 5.5 | (1.1) | (1.6) | (0.2) | (2.0) |
| Cash From Financing Activities | 63.0 | 11.6 | 149.0 | 51.5 | 22.6 | 25.0 | 9.5 | 13.9 | 10.7 | 10.0 | 9.9 | 1.4 | 10.5 K |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | 54.4 | (134.4) | 109.4 | 31.1 | (1.6) | 9.9 | (2.8) | 0.4 | (1.2) | (0.7) | 5.9 | 25.4 K | 31.9 K |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | (57.4) | (44.6) | (39.6) | (20.4) | (24.2) | (15.4) | (14.1) | (13.7) | (12.6) | (10.2) | (3.2) | (1.6) | 42.4 K |